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Implantation is a frequent procedure in orthopedic surgery, particularly in the aging population. However, it possesses the risk of
infection and bioﬁlm formation at the surgical site. This can cause unnecessary suﬀering to patients and burden on the healthcare
system. Pure Mg, as a promising metal for biodegradable orthopedic implants, exhibits some antibacterial eﬀects due to the alkaline
pH produced during degradation. However, this antibacterial eﬀect may not be suﬃcient in a dynamic environment, for example,
the human body. The aim of this study was to increase the antibacterial properties under harsh and dynamic conditions by alloying
silver metal with pure Mg as much as possible. Meanwhile, the Mg-Ag alloys should not show obvious cytotoxicity to human
primary osteoblasts. Therefore, we studied the inﬂuence of the microstructure and the silver content on the degradation
behavior, cytocompatibility, and antibacterial properties of Mg-Ag alloys in vitro. The results indicated that a higher silver
content can increase the degradation rate of Mg-Ag alloys. However, the degradation rate could be reduced by eliminating the
precipitates in the Mg-Ag alloys via T4 treatment. By controlling the microstructure and increasing the silver content, Mg-Ag
alloys obtained good antibacterial properties in harsh and dynamic conditions but had almost equivalent cytocompatibility to
human primary osteoblasts as pure Mg.
1. Introduction
The clinical application of biodegradable implant and pros-
thesis has shown rapid growth to keep with the demands of
a rapidly aging population. However, implant-associated
orthopedic surgery infections are common postoperative
wound infections and can cause bioﬁlm formation on the
implants or bones [1, 2]. Bioﬁlms are resistant to antibiotics
and can protect bacteria from host immune mechanisms.
Once a bioﬁlm has formed, the only treatment is to remove
the implant and the diseased tissue [3–5]. Prevention is the
preferred method to address the growing problem of
implant-associated infections [6, 7].
Pure magnesium (pure Mg) and its alloys, as potential
biodegradable implant materials, have the advantage of not
requiring removal after bone tissue healing [8]. Therefore,
infection caused by a second surgery can be avoided. In vitro,
pure Mg exhibited some antibacterial properties due to its
alkaline pH [9–11]. In the early stage of degradation, it can
create an alkaline environment, which is adverse to the sur-
vival and reproduction of bacteria [12, 13]. However, it is
not clear whether these changes will occur in vivo, although
it was shown that pure Mg induces osteoblasts and
suppresses bacteria in a chronically infected rabbit tibial oste-
omyelitis model [14]. However, the length of time that an
eﬀective antibacterial concentration maintained in the local
position is not suﬃcient, which will inﬂuence the resistance
to infection and will aﬀect osteomyelitis treatment [14, 15].
One cause of these eﬀects is that the degradation rate of pure
Mg and magnesium alloys in vivo is lower than that in vitro
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[16–18]. In this case, a high pH cannot be maintained, so it
sounds unrealistic for pure Mg or its alloys to achieve long-
term inhibition to bacteria.
Silver (Ag) has eﬀective antibacterial properties and has
been used to treat burns and chronic wounds for centuries
[19]. Silver nanoparticles (AgNPs) and silver ions can bind
to proteins, change the membrane of bacteria, interfere with
DNA expression, create reactive oxygen species (ROS), and
aﬀect thiol group compounds that exist in respiratory
enzymes to inhibit respiratory processes [20–22]. The emer-
gence of antibiotic-resistant strains of bacteria has promoted
the use of metallic silver to prevent infections of indwelling
devices [20]. There are cases of silver applications that focus
on the antibacterial properties, for example, wound dress-
ing, bone cement, and megaprosthesis [23–25]. Silver-
coated megaprosthesis can release silver ions and reduce
the infection rate compared to the group without silver
[25]. In addition, metallic silver can stimulate osteogenic
diﬀerentiation [26].
However, the accumulation of a high amount of silver in
the human body can cause argyria or argyrosis, which results
from the deposition of signiﬁcant amounts of insoluble silver
precipitates in the dermis of the skin and the cornea or
conjunctiva of the eyes [27, 28]. However, no pathological
damage to tissues can be observed. The threshold amount
of silver that can evoke argyria ranges from 3.8 to 5 g or even
10 g over the whole lifetime of adults [29]. The total body
silver concentration that can cause argyria is 1 g for children
under 10 years old [30]. Hence, the application of silver in the
human body should consider these limitations. In clinical
course, the amount of silver coated on megaprosthesis ranges
from 0.4 to 1.69 g in adult patients [25]. However, no relevant
evidence shows that such a low amount of silver in the
human body or chronic silver exposure can cause pathologi-
cal changes in any tissue or organ [27–29, 31]. Moreover, the
loss of cell viability in vitro due to metallic silver or silver
compounds is dose dependent [26, 32, 33]. Metallic silver
has a lower risk of toxic eﬀects compared with soluble silver
compounds [34].
How to avoid or treat orthopedic implant contamination
and bioﬁlm formation is a complicated issue [35]. Novel, bio-
degradable magnesium alloys with antimicrobial properties
are desirable considering the surgical contamination and
appearance of multiresistance bacteria. Many methods have
been studied, for example, coating and surface morphology,
to endow permanent implants or even magnesium alloys
the function of suppressing bacteria or reducing bacterial
adhesion [20, 36–39]. However, maintaining long-term and
stable prevention of implant-associated infection remains a
problem [40]. In addition, the current methods cannot main-
tain the long-term antibacterial properties of biodegradable
magnesium alloys.
In this study, metallic silver was alloyed with pure Mg so
that the silver could be released continuously and react with
bacteria if the bacteria attach to the surface of Mg-Ag alloy
or the surrounding tissue during the whole degradation
period. We planned to reach the best antibacterial properties
of Mg-Ag alloys by alloying silver inside as much as possible
and obtain good cytocompatibility comparable to those of
pure Mg by adjusting their microstructure via thermal-
mechanical processing and heat treatment. It is expected that
bioﬁlms cannot form on the Mg-Ag alloy and surrounding
tissue, even in a harsh environment with a large amount of
bacteria and under ﬂow conditions, for example, the human
body. By this method, it is hoped that implant-associated and
recurrent infections can be prevented successfully when Mg-
Ag alloy is used as a bone implant in the future.
2. Material and Methods
2.1. Materials Preparation.Magnesium (99.99wt%, Xinxiang
Jiuli Magnesium Co., Ltd., Xinxiang, China) and silver gran-
ules (99.99wt%, ESG Edelmetall-Handel GmbH & Co. KG,
Rheinstetten, Germany) were used for the preparation of
Mg-6Ag and Mg-8Ag alloys. Pure magnesium was cut into
small pieces and placed in a steel crucible with the corre-
sponding amount (6wt% or 8wt%) of silver. The metals were
melted at 750°C under a protective atmosphere of 98% Ar
(argon) and 2% SF6 (sulphur hexaﬂuoride) and then stirred
for 30minutes at 200 rpm. After the temperature decreased
to 730°C, the melt was transferred to a permanent steel
mould (diameter ø = 120mm) that was coated inside with
the mould release agent ALU-STOP LC25 (Büro für ange-
wandte Mineralogie, Dr. Stephan Rudolph, Tönisvorst,
Germany). The mould was held for 15min at 680°C under
a protective atmosphere and was then immersed in ﬂowing
room temperature water gradually at a speed of 100 cm/min
until the melted magnesium alloy solidiﬁed. Pure Mg ingots
were recast into cylinder shape following the same solidiﬁca-
tion procedure. The tops and bottoms of the ingots with
shrinkage and impurities were removed. The contents of
elements in the Mg-Ag alloys were analyzed by X-ray
ﬂuorescence (Bruker AXS S4 Explorer, Bruker AXS
GmbH, Germany) and with a Spark Analyser (Spectrolab
M, Spektro, Germany).
According to the Mg-Ag phase diagram, silver has low
solubility of 15wt% in magnesium at eutectic temperature
which is the lowest melting point of a mixture of components
[41]. Homogenization treatment and hot extrusion were per-
formed to acquire a homogeneous microstructure and stable
mechanical properties. The homogenization treatment was
conducted in a resistance furnace (Linn Elektro Therm AK
40. 06, Bad Frankenhausen, Germany) at 430°C for 16 h,
followed by quenching in room temperature water. The
ingots were then heated up (285°C for Mg-6Ag and 300°C
for Mg-8Ag) and processed by hot extrusion (Strangpress-
zentrum Berlin, Berlin, Germany), for which the extrusion
ratio and the advance rate of stamp were 108 and 0.7mm/s,
respectively. The temperature of the container and steel die
was 300°C. The extruded rods (ø = 12mm) were cut into
discs (ø = 10mm and h = 1 5mm) (Henschel KG, Munich,
Germany). T4 heat treatment (solution treatment) of the
discs was conducted by placing them in a steel box ﬁlled
with Ar and holding them in a resistance furnace
(Vulcan™ A-550, Dentsply Ceramco, USA) at 450°C for
8 h and before quenching. The discs were ground on sand-
paper (2500#, mesh) to remove the oxidation layer caused
by heat treatment.
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2.2. Microstructure Analysis. Samples were prepared by
grinding on sandpaper from 220# to 2500#, followed by pol-
ishing using water-free OPS (oxide polishing suspension) on
a rubber plate. The samples were etched in picric solution
(100mL ethanol, 20mL distilled water, 6-7mL glacial acetic,
acid and 12–15 g picric acid (99%), all chemicals from Sigma-
Aldrich Chemie, Taufkirchen, Germany) and were observed
by polarized light microscopy (Leica 020-520.008 DM/LM,
Wetzlar, Germany) and scanning electron microscopy
(SEM, TESCAN vega 3 SBU, Brno, Czech Republic). The
precipitates in the extruded Mg-Ag alloy were characterized
by Bruker X-ray diﬀraction (XRD).
2.3. Immersion Test. An optimized in vitro test setup was
used for the immersion tests [42, 43]. Cell culture medium
(CCM), Dulbecco’s Modiﬁed Eagle’s Medium (DMEM),
and GlutaMAX +10% FBS (fetal bovine serum, PAA labora-
tories, Linz, Austria) were used for the immersion test and
cell culture. The cell culture conditions were 5.0% CO2,
20%O2, 37.0
°C, and 97.0% rH (relative humidity). Discs were
weighed by a Scaltec SBA32 (Scaltec, Goettingen, Germany)
and sterilized ultrasonically in 70% ethanol solution for
30min. After drying, the discs were transferred to 12-well
plates, which were ﬁlled with 2mL CCM in each well, and
then incubated in the cell culture conditions for 1 week.
The old cell culture medium was replaced by a fresh one after
48 and 120 hours. After the immersion test was carried out
for 168 hours, the degradation products were removed by
chromic acid (180 g/L in a. dest., Sigma-Aldrich Chemie,
Taufkirchen, Germany). The discs were dried in a vacuum
box and weighed by the precision electronic balance. The
mean degradation rate was calculated using the previously
described weight loss method [44].
2.4. Cytotoxicity Test. Human primary osteoblasts were
selected for the cytotoxicity evaluation. The human primary
osteoblasts came from patients undergoing total hip arthro-
plasty with local ethical committee agreement. Pure Mg and
Mg-Ag discs were sterilized ultrasonically in 70% ethanol
solution for 30min. Extracts of pure Mg and Mg-Ag for the
MTT assay were prepared by immersing samples into CCM
(0.2 g/mL) for 3 days in the cell culture conditions. The con-
centration of Mg, calcium (Ca), and Ag in the extracts was
measured via inductively coupled plasma mass spectrometry
(ICP-MS; Agilent 7700x ICP-MS, Waldbronn, Germany).
The extracts were further characterized by measuring their
pH and osmolality at room temperature using an ArgusX
pH meter (Sentron, Roden, Netherlands) and a Gonotec
030-D cryoscopic osmometer (Gonotec, Berlin, Germany),
respectively. A 50μL aliquot of CCM containing 2000 human
primary osteoblasts was seeded into each well of 96-well
plates. The plates were transferred to the incubator and kept
in the cell culture conditions for 24 hours to ensure that the
human primary osteoblasts attached to the bottom. The
diluted pure Mg and Mg-Ag extracts were prepared by
adding CCM at ratios of 1 : 5 and 1 : 10. Then, the old CCM
was replaced with fresh CCM (control group), pure Mg and
Mg-Ag extracts, and diluted extracts (n = 6 for each
concentration). After culturing for 3 days, 10μL 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide solu-
tion (MTT) (Sigma-Aldrich, Steinheim, Germany) was added
to each well and incubated for 4 hours. Then, 100μL SDS
(sodium dodecyl sulphate) lysis buﬀer (Sigma-Aldrich Co.,
LLC, Steinheim, Germany) was added into the wells and incu-
bated overnight. Finally, the values were measured using an
ELISAmultiwell plate reader (Tecan, Maennedorf, Switzerland)
and the background value was removed.
In the adhesion test, pure Mg and Mg-Ag discs were
placed in 12-well plates after the discs incubated in CCM in
the cell culture conditions for 24 hours. A total of 105 human
primary osteoblasts were seeded on the surface of each disc.
To ensure that the human primary osteoblasts attached to
the surface, the seeded samples were kept in the incubator
for 30min. Then, 12-well plates were slowly ﬁlled with
3mL of fresh CCM and transferred into the incubator and
cultured for 3, 6, or 9 days. The CCM was changed every 3
days. The pH and osmolality of the replaced medium were
measured. Discs were washed gently in sterilized and distilled
water and transferred into wells ﬁlled with LIVE/DEAD®
Viability/Cytotoxicity Kit (Molecular Probes, Eugene, USA)
according to the manufacturer’s protocol. After incubation
for 20min, the distribution and viability of human primary
osteoblasts on pure Mg and Mg-Ag discs were observed via
ﬂuorescent microscope (Nikon Eclipse Ti-S, Tokyo, Japan).
2.5. Bioﬁlm Test and Evaluation. The bioﬁlm test was
conducted in a bioreactor system (Figure 1). This dynamic
system has a cross-ﬂow condition in the chambers, which
ensures that the bacteria go through the surface of the discs.
The ﬂow rate of the medium in chamber was 0.3mL/min.
These conditions allow the possibility of initial bioﬁlm for-
mation on the discs [45]. During the running time of 15
hours, the temperature and pH were 37°C and 7.2, respec-
tively. All the parameters mentioned above were controlled
by the bioreactor system (BioFlo®/CelliGen® 115 (New
Brunswick™), Eppendorf AG, New Brunswick, USA). Refer-
ence discs (titanium (Ti)) were always used as an internal
control for the test. Pure Mg and Mg-Ag alloys were treated
with 25.0 kGy gamma sterilization (BBF Sterilisationsservice
GmbH, Kernen, Germany) before the bioﬁlm test [44]. The
whole test was performed in a microaerophilic and sterilized
environment to ensure bacterial activity. The bacteria culture
medium (BCM) consisted of nutrient broth (pH=7.2), 3 g
meat extract, 5 g peptone (Sigma-Aldrich Co., LLC, Stein-
heim, Germany), and 1L distilled water. Phosphate-
buﬀered saline (PBS, pH=7.4) was prepared with 8 g
NaCl, 0.2 g KCl, 1.47 g Na2HPO4, 0.24 g KH2PO4 (Sigma-
Aldrich Co. LLC, Steinheim, Germany), and 1L double-
distilled water.
Staphylococcus aureus (S. aureus, DSM number 20231)
and Staphylococcus epidermidis (S. epidermidis, DSM num-
ber 3269) were used in the bioﬁlm test. These bacteria are
commonly found in implant-associated orthopedic infec-
tions or osteomyelitis [3, 46–48], although there is conten-
tion about which is the most common bacteria isolated
from clinical infections, especially implant-associated infec-
tions [49–51]. The bacteria were provided by the Leibniz
Institute DSMZ-German Collection of Microorganisms and
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Cell Cultures in Germany. The bacteria were cultured
overnight and were mixed and imported into the bioreac-
tor system after checking their viability. The density and
ratio of the mixed bacteria in medium were 106 /mL and
1 : 1, respectively.
After the bioreactor system ran for 15 hours, all of the
discs were removed from the chamber and labelled by adding
LIVE/DEAD BacLight™ Bacterial Viability Kit (Thermo
Fisher Scientiﬁc Inc. (Life Technologies), Eugene, USA).
Some discs were observed by confocal laser scanning micros-
copy (CLSM, LSM 710, Carl Zeiss Microscopy GmbH, Jena,
Germany). Images of the whole surface and the local details
of the discs were taken by CLSM. The other discs (n = 12
for each type of sample) were rinsed gently in distilled water,
placed in glass bottles with PBS, and transferred to an ultra-
sonic bath (SONOREX SUPER 10P, BANDELIN electronic
GmbH & Co. KG, Berlin, Germany). A plastic scraper was
used to remove the bacteria from the surfaces of the discs
under sonication. The PBS solutions containing bacteria
were diluted, placed on a counting chamber, and counted
using a ﬂuorescence microscope (BX51, Olympus Optical
Co. (Europa) GmbH, Hamburg, Germany).
2.6. Sample Preparation for SEM and Generation of 3D
Images. In adhesion test, the procedures to prepare the
SEM samples with human primary osteoblasts were ﬁxation
in 2.5% glutaraldehyde solution in buﬀer (Sigma-Aldrich
Co. LLC, Steinheim, Germany) for 2 hours, staining in 1%
osmium tetroxide (Sigma-Aldrich Co. LLC, Steinheim,
Germany) for 30min, dehydration for 1 hour using increas-
ing concentrations of 2-propanol (EMSURE®, Darmstadt,
Germany) (20%, 40%, 60%, 80%, and 100%), and critical point
drying (Leica EM CPD030, Bal-TEC AG, Balzers, Liechten-
stein). Then, the samples were placed on an SEM sample
holder with N650 Planocarbon (Plano GmbH, Wetzlar,
Germany). In bioﬁlm test, three-dimensional (3D) images of
the discs were merged using SEM pictures with diﬀerent tilt
angles (0°, 7°, and 15°) before and after removal of the
degradation products.
2.7. Data Analysis. Statistical analyses were performed by
one-way analysis of variance (ANOVA) in Origin 9.0G with
the appropriate post hoc comparison test (Tukey’s test). A p
value <0.05 was considered signiﬁcant. The graphs present
the results as the mean value with the standard deviation
(SD) as the error bars.
3. Results
3.1. Metallography and Microstructure. The actual elemental
composition of theMg-Ag alloys is listed (Table 1). PureMg has
a similar grain size as extruded Mg-6Ag. Extruded Mg-8Ag has
ﬁner grains (average grain size AGS = 7 9 ± 4 5 μm) than
extruded Mg-6Ag (AGS = 28 2 ± 13 4 μm). However, the grain
size increased obviously after the T4 treatment and showed a
nonuniform trend, but the microstructures of Mg-6Ag and
Mg-8Ag became similar after T4 treatment (Figure 2). Accord-
ing to the XRD patterns, the precipitates in the extruded Mg-
6Ag and Mg-8Ag are Mg54Ag17 (Figure 3(b)). Most of the
precipitates are distributed along the grain boundaries of the
extruded Mg-Ag alloys, as shown in the SEM images. There is
a small amount of precipitate (0.2%) in the extruded Mg-6Ag
Heating system
Heating system
Chamber
Motor
pH control
system
Medium renew
system
Pump
Figure 1: Schematic diagram of the bioreactor system.
Table 1: Major and trace element composition of the Mg-Ag alloys.
Alloys Ag wt% Fe wt% Cu wt% Ni wt% Mg wt%
Mg-6Ag 6.26 0.00205 0.00100 0.00108 Balance
Mg-8Ag 8.51 0.00184 0.00104 0.00106 Balance
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Figure 2: Metallography, distribution, and quantity of secondary phases and precipitates in the extruded Mg-Ag alloys before and after T4
treatment. The grain sizes of extruded pure Mg, extruded Mg-6Ag, T4-treated Mg-6Ag, extruded Mg-8Ag, and T4-treated Mg-8Ag are 29.9
± 15.5, 28.2± 13.4, 154.5± 103.4, 7.9± 4.5, and 159.9± 89.7μm, respectively. The SEM in BSE (back-scattered electron) mode was used. The
ratios of second phases and precipitates in the extruded Mg-6Ag and Mg-8Ag are 0.2% and 2.3%, respectively.
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Figure 3: (a) Surface morphology of discs after the immersion test. The images of the local details are in BSE mode. (b) XRD pattern of the
extruded Mg-8Ag alloy. (c) The mean degradation rate of pure Mg and Mg-Ag alloys in CCM in the cell culture conditions. The mean
degradation rate of the extruded Mg-8Ag is signiﬁcantly higher than the others. The “∗” indicates a signiﬁcant diﬀerence compared with
the other values, p < 0 05.
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and a large amount (2.3%) in the extruded Mg-8Ag. Some
larger particles can be found in the extruded Mg-6Ag and
Mg-8Ag that are residuals of the secondary phase after the
homogenization treatment of the ingots. After T4 treatment,
nearly all the secondary phases and precipitates in the extruded
Mg-Ag alloys dissolved into the alloys.
3.2. Morphology and Degradation Rate. After the immersion
test, the surface condition of the discs can be observed
(Figure 3(a)). Some black or white dots, which are degrada-
tion products, are present on the surface of the pure Mg
and Mg-Ag alloys in low-magniﬁcation images. However,
the extruded Mg-8Ag disc showed more severe degradation
than the other discs. Loose degradation products and accu-
mulated silver are observed on the surface. There is also
some accumulated silver on the surface of the extruded
Mg-6Ag disc. However, there are only cracks on the pure
Mg and T4-treated Mg-Ag discs after the degradation layer
is dehydrated.
The addition of silver led to a slight increase in the
degradation rate of Mg-6Ag alloy compared to pure Mg
(Figure 3(c)). A further increase in silver signiﬁcantly
enhanced the degradation to 3.47mm/year. This eﬀect could
be drastically reduced by T4 treatment, which led to degrada-
tion rates of less than 0.5mm/year. In this case, the degrada-
tion rate increased linearly with the amount of silver.
3.3. Cytocompatibility
3.3.1. MTT. The pH and osmolality of the extracts from the
pure Mg and extruded Mg-Ag alloys were elevated compared
to the CCM (Table 2). More Mg existed in the extracts than
in CCM, but the concentration of Ca in the extracts
decreased (Table 3). Magnesium/calcium phosphates formed
in the degradation layer during degradation [52–55]. After
T4 treatment, the osmolality of the Mg-Ag alloy extracts
was lower than that of the pure Mg and extruded Mg-Ag
extracts. The concentrations of Mg, Ca, and Ag in the pri-
mary extracts from extruded Mg-Ag were higher than those
from T4-treated Mg-Ag.
In the MTT assay, all primary extracts, including pure
Mg extract, showed cytotoxicity compared with CCM
because of high pH and osmolality (Figure 4). Their values
were below the cytotoxic limit of 75% cell viability. After
ﬁvefold dilution, most of the extracts did not show
cytotoxicity, except for the extract of the extruded Mg-
8Ag, which also did not reach the level of 75% because
the silver concentration was still higher than the tolerance
of human primary osteoblasts. After ﬁvefold and tenfold
dilutions, the extract from T4-treated Mg-8Ag showed
good cytocompatibility as did the diluted pure Mg extracts
and CCM, although all primary extracts exhibited cytotox-
icity to human primary osteoblasts.
3.3.2. Live/Dead Staining and Adhesion Test. The pH and
osmolality were measured after preincubation for 24 hours
and culturing human primary osteoblasts on the samples
Table 2: Increments of pH and osmolality of pure Mg and Mg-Ag
alloys compared to those of CCM.
Extracts pH Osmol/kg
Pure Mg (extrusion) 0.815 0.107
Mg-6Ag (extrusion) 0.920 0.110
Mg-6Ag (T4) 0.955 0.066
Mg-8Ag (extrusion) 0.895 0.104
Mg-8Ag (T4) 0.965 0.068
Table 3: Calculated concentrations of elements in the extracts of
extruded pure Mg and Mg-Ag alloys.
Extracts Dilution
Concentration (mg/L)
Mg Ca Ag
Pure Mg (extrusion)
1 1210 27 <0.1
1/5 258 65.4 <0.1
1/10 139 70.2 <0.1
Mg-6Ag (extrusion)
1 1280 26 1.2
1/5 272 65.2 0.24
1/10 146 70.1 0.12
Mg-6Ag (T4)
1 1010 17 0.31
1/5 218.8 62.6 0.062
1/10 119.9 68.3 0.031
Mg-8Ag (extrusion)
1 1150 25 104
1/5 246 65 20.8
1/10 133 70 10.4
Mg-8Ag (T4)
1 930 15 0.64
1/5 202.8 62.2 0.128
1/10 111.9 68.1 0.064
Cell culture medium (CCM) 20 75 <0.1
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Figure 4: Viability of human primary osteoblasts determined by
MTT assay in the primary, 1 : 5, and 1 : 10 extracts. The dotted line
marks 75% cell viability, which indicates no potential cytotoxicity
[58]. The “∗” indicates statistically signiﬁcant diﬀerence at p < 0 05
versus the control group (CCM).
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Figure 5: (a) Variation of pH and osmolality during the incubation. (b) Live/dead staining of human primary osteoblasts on pure Mg and
Mg-Ag alloys. The clear green parts represent living osteoblasts and the red dots dead osteoblasts. (c) SEM images of the adhesion tests of
human primary osteoblasts. The ﬁrst and second vertical rows show thick cell layers covering the surface after 9 days. The third vertical
row shows the status of a single osteoblast attached to the degradation layer after 3 days.
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for 3, 6, and 9 days. The pH of the pure Mg and T4-treated
Mg-Ag discs decreased gradually over time (Figure 5(a)).
The osmolality of the extract from pure Mg was stable, and
the osmolality of the extract from extruded Mg-6Ag
increased slightly over time. However, the osmolality of the
extract from extruded Mg-8Ag remained at a high level after
preincubation, and it had nearly the highest pH and osmolal-
ity at all time points. The extracts of the T4-treated Mg-Ag
discs had higher osmolality after preincubation, but the
osmolality decreased rapidly over time.
The regions with the same cell density were selected for
comparison after live/dead staining (Figure 5(b)). The degra-
dation rates of the extruded pureMg andMg-6Ag were much
lower than those of the extruded Mg-8Ag in CCM in the cell
culture conditions according to the pH and osmolality
(Figure 5(a)). Human primary osteoblasts can survive and
attach to extruded pure Mg, extruded Mg-6Ag, and T4-
treated Mg-6Ag discs. After 3 days, on pure Mg and Mg-
6Ag, some dead osteoblasts were detected. After 6 days, the
number of dead osteoblasts decreased. After 9 days, no diﬀer-
ences were detected between the viability of human primary
osteoblasts on pure Mg and Mg-6Ag discs. However, the
extract from the extruded Mg-8Ag always had the highest
average pH and osmolality, which indicates a faster degrada-
tion rate. The pH and osmolality near the surface of the
extrudedMg-8Ag discs were higher, so many bubbles formed
on the surface and a large amount of silver was released. As a
result, no human primary osteoblasts attached to and sur-
vived on the extruded Mg-8Ag discs. After T4 treatment,
the pH and osmolality of Mg-8Ag discs were lower and
showed better cytocompatibility than before. Human pri-
mary osteoblasts can attach and proliferate on T4-treated
Mg-8Ag discs as well as on pure Mg and Mg-6Ag discs, but
a slightly higher amount of dead cells was observed in the ini-
tial stage (after 3 days). Cell layers and the details of human
primary osteoblasts could be observed on all surfaces of the
Mg-Ag discs, except for the extruded Mg-8Ag disc, where
there are only degradation products (Figure 5(c)).
3.4. Bioﬁlm Test
3.4.1. Viability of Bacteria. The extruded Mg-Ag alloys
showed the best antibacterial eﬀect (Figure 6). The viability
of bacteria was much lower on theMg-Ag alloys than on pure
Mg. There was a relative high viability of bacteria on pure Mg
of 50.35%. However, the viability on T4-treated Mg-6Ag and
Mg-8Ag discs was 18.64% and 14.75%, respectively, which
was signiﬁcantly lower than that on pure Mg. In addition,
more bacteria were observed on T4-treated Mg-Ag discs than
on the extruded Mg-Ag discs.
3.4.2. Bioﬁlm Culture. In the bioﬁlm test, incubation for 15
hours can form an initial bioﬁlm on Ti discs, which were
set as the negative control for internal evaluation. A nearly
complete young bioﬁlm can be observed on the Ti disc
(Figure 7(a)). A large amount of live bacteria on Ti disc could
be observed in the high-magniﬁcation images (Figure 7(b)).
The total amount of bacteria on pure Mg is obviously lower
than on Ti disc. Extruded Mg-Ag discs showed local pitting
degradation and had a faster degradation rate in BCM with
a constant pH (7.2) than in CCM (Figure 7(a)). Many dead
bacteria were present on the extruded Mg-Ag discs based
on the overview pictures. However, the overview of the
bioﬁlm showed no obvious diﬀerence between pure Mg and
T4-treated Mg-Ag discs. By judging from the high-
magniﬁcation images (Figure 7(b)), details of live and dead
bacteria on the T4-treated Mg-Ag alloys were shown. Most
of the bacteria on the surface of the T4-treated Mg-Ag discs
were dead compared to the bacteria on pure Mg.
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3.4.3. Surface Morphology after the Bioﬁlm Test in the Flow
System. The 3D images of pure Mg and T4-treated Mg-
Ag discs before and after removal of the degradation
products are shown (Figure 8). The surfaces of the discs
with degradation products appear coarse. It can be
observed that many degradation products are present on
the surface of the pure Mg and Mg-Ag discs. There are
also some needle-like crystals on the T4-treated Mg-6Ag
disc and many needle-like crystals on the T4-treated Mg-
8Ag disc, so they look very rough in the 3D images. How-
ever, after removal of degradation products, the peaks
disappeared and many degradation pits were revealed,
especially on pure Mg, where a porous surface was
exposed. However, only shallow and broad pits were
observed on the surface of T4-treated Mg-Ag discs, which
indicates a more homogeneous degradation mechanism.
The average roughness (Sa) of pure Mg, T4-treated Mg-
6Ag, and T4-treated Mg-8Ag are 8.68± 0.8, 6.42± 0.42,
and 8.88± 1.92, respectively, and the developed interfacial
areas (Sdr) are 37.87± 1.44, 19.26± 2.72, and 22.39± 2.23,
respectively. Therefore, the Sa of pure Mg and T4-treated
Mg-Ag alloys is on the same level, and the Sdr of the
T4-treated Mg-Ag alloys is signiﬁcantly lower than that
of the pure Mg at p < 0 05. Therefore, the T4-treated
Mg-Ag alloys have less contact area with the medium than
pure Mg during degradation.
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Figure 7: (a) Overview of bioﬁlm formation. (b) Details of bacteria on discs.
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4. Discussion
Silver release plays a key role in eliminating multiple bacteria
and preventing bioﬁlm formation [23]. The novel point is
that the addition of silver to pure Mg signiﬁcantly improved
the antibacterial eﬀect in a dynamic environment because sil-
ver was released from the matrix continuously during the
whole degradation of Mg-Ag alloy as an orthopedic implant.
In a previous study with cast material, the eﬀect of silver
addition could already be demonstrated [56]. However, cast
magnesium alloys would never be used to produce implants.
Therefore, in this study, extruded Mg-Ag alloys were evalu-
ated. Extrusion generally led to a ﬁner microstructure and
was associated with lower degradation rates, imbalancing
the silver release. Therefore, we evaluated higher silver con-
tents in this study. We found that Mg-Ag alloys possessed
much higher degradation rates when the silver content
reached in magnesium 8wt%. The high pH, osmolality, and
silver concentration had negative eﬀects on the viability of
human primary osteoblasts, although good antibacterial
properties were shown in dynamic conditions. T4 heat treat-
ment decreased the degradation of Mg-Ag alloys. As a result,
human primary osteoblasts could survive on the surface of
T4-treated Mg-Ag alloys. Meanwhile, the Mg-Ag alloys still
had a much better antibacterial eﬀect than pure Mg.
Silver has a major inﬂuence on the degradation behav-
ior of Mg-Ag alloys. Since it has low solubility in magne-
sium at ambient temperature [41], more secondary phases
Pure Mg
(extrusion)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Z (휇m)
400.0
200.0
0.0
0.8
0.6
0.4
0.2
0.0
‒0.2
‒0.4
‒0.6
‒0.8
‒1.0
‒0.8
‒0.6
‒0.3
0.0
Y (mm)
0.3
0.5
0.8
1.0
X (mm)
Be
fo
re
A
e
r
Mg-6Ag
(T4)
Mg-8Ag
(T4)
Figure 8: 3D images and surface conditions (SEM) before and after removal of the degradation products. The average roughness (Sa) of pure
Mg, Mg-6Ag, and Mg-8Ag are 8.68± 0.8, 6.42± 0.42, and 8.88± 1.92, respectively. The developed interfacial areas (Sdr) are 37.87± 1.44,
19.26± 2.72, and 22.39± 2.23.
10 Oxidative Medicine and Cellular Longevity
or precipitates exist in Mg-Ag alloys when the silver
content is higher [56]. Both the amount and distribution of
precipitates can aﬀect the degradation behavior due to the
principle of microgalvanic corrosion [12, 54]. The degrada-
tion rate increases linearly with increasing quantity of precip-
itates and the precipitates can cause localized degradation
phenomenon [57]. For example, the extruded Mg-8Ag had
higher degradation rate than the extruded Mg-6Ag. T4 treat-
ment near the eutectic temperature can eliminate the second-
ary phases and precipitates. Since the Mg54Ag17 precipitates
did not have the ability to restrict the migration of grain
boundaries at high temperature, the grains were enlarged
during T4 treatment. The elimination of precipitates weak-
ened galvanic corrosion, so the degradation rate decreased
[12]. For pure Mg and T4-treated Mg-Ag alloys, they had dif-
ferent grain sizes and both of them had no precipitates inside.
T4-treated Mg-6Ag had nearly the same degradation rate
compared to pure Mg. T4-treated Mg-6Ag had bigger grains
than pureMg, so grain size was not the key factor to inﬂuence
the degradation rate. T4-treatedMg-6Ag and T4-treatedMg-
8Ag had no signiﬁcant diﬀerence of grain size. However, T4-
treated Mg-8Ag had higher degradation rate than T4-treated
Mg-6Ag to some extent. In this case, solid solution of silver in
magnesium inﬂuenced the degradation rate when it reached
8wt%. The pure Mg and T4-treated Mg-Ag alloys had lower
degradation rates than the extruded Mg-Ag alloys in CCM.
T4-treated Mg-Ag alloys had more homogeneous and ﬂatter
degradation surfaces and lower pitting degradation trends
than pure Mg in the ﬂow chamber according to the 3D
images, even though the low pH (7.2) of BCM had an adverse
eﬀect on the stability of the degradation layer [57]. The mor-
phology diﬀerence was related to the solution of silver and
microstructural changes via T4 treatment. Hence, the exis-
tence of precipitates mainly inﬂuenced the degradation
behavior followed by solution of silver rather than grain size.
The degradation rate of Mg-Ag alloys can inﬂuence the
pH and osmolality of the medium and silver release, which
are closely related to cytocompatibility [43]. A high degrada-
tion rate largely leads to increased pH, osmolality, hydrogen
generation and silver release. However, the pH will not
always increase linearly with the degradation rate because
of a “saturation eﬀect”. The increment of osmolality is
because of Mg ion release instead of Ca and other ions.
According to the MTT and adhesion test, high pH, osmolal-
ity, and silver contents can cause cytotoxicity to human
primary osteoblasts, for example, extruded Mg-8Ag. It is also
not easy for cells or bacteria to attach to the surface due to the
hydrogen generation, although good antibacterial properties
can be obtained. For pure Mg, the cytotoxicity of the primary
extract is caused by the high pH and osmolality. Similarly,
pure magnesium cannot rely on a high pH to achieve its
antibacterial eﬀect, regardless of cytotoxicity, because high
osmolality or magnesium ion concentration causes osmotic
shock in human cells [58]. Therefore, a high degradation rate
is not required of magnesium alloys used as orthopedic
implants, and the degradation rate should be controlled to
meet the cytotoxicity criteria ﬁrst.
The bioﬁlm assay was conducted under ﬂowing condi-
tions. The in vitro design of the dynamic system with large
numbers of bacteria in the ﬂowing medium represents harsh
conditions, although the in vivo conditions normally show
clearly lower bacteria concentrations. The ﬂowing conditions
and pH control system can exclude the pH eﬀect of the cor-
roding Mg alloys as much as possible. Pure Mg did not show
satisfactory antibacterial properties under these conditions.
Based on the viability of bacteria on pure Mg discs, there
are still considerable numbers of live bacteria that should
not be neglected. From the overview of the bioﬁlm and bac-
teria distribution on the discs, it appears that pure Mg has
the potential to form many colonies or a bioﬁlm layer under
suitable conditions, although the total amount of bacteria
is less than that on the negative control groups [59].
Admittedly, the pH plays an important antibacterial role
due to the alkaline environment created during degradation
[9–11]. The alkaline environment has adverse eﬀects on bac-
teria in static conditions. It is unclear whether pure Mg has
suﬃcient antibacterial properties in these conditions in a
dynamic environment, such as the human body.
There was a large amount of silver released from the
extruded Mg-Ag alloys because of high degradation rate. As
a result, they showed good antibacterial properties. However,
the viability of bacteria was not as low as expected, for exam-
ple, 99.9%. One reason is that a large portion of silver ﬂowed
away with the medium and another reason is that a large
amount of bacteria (106/mL) exists in the medium, which
indicates harsh conditions. The T4-treated Mg-Ag alloys
got better antibacterial properties than pure Mg. T4-treated
Mg-8Ag released more silver (twofold) than T4-treated Mg-
6Ag, but bacteria viability decreased only by 4 percent due
to the ﬂow system of the bioreactor. In this case, less-
released silver ions reacted with the bacteria attached to the
surface of the discs. According to the decreasing trend of bac-
teria viability, if we continue to increase the silver content in
pure Mg, for example, 15wt%, more eﬀective antibacterial
properties of Mg-Ag alloy could theoretically be achieved in
the bioreactor. However, the degradation rate approaches
its limit at an acceptable range for orthopedic implants [60].
Silver ions can bind strongly and build complexes with
thiols, metallothionein, albumins, and macroglobulins
in vivo [29, 61, 62]. The antibacterial properties of Mg-Ag
alloys are related to the silver concentration in the infection
site, which is determined by the amount of silver in the
Mg-Ag alloys and its release rate. If only a small amount of
silver was released, the remaining silver was not suﬃcient
to inhibit bacteria. In contrast, if the amount of active silver
ions released was greater, the antibacterial properties would
be more eﬀective [25], so it is better to alloy as much silver
as possible in pure Mg to ensure eﬀective antibacterial prop-
erties on the basis of a controllable degradation rate. How-
ever, the total silver in the Mg-Ag alloy should not exceed
the amount that can cause argyria in the human body.
5. Conclusion
In this study, the relationship between the microstructure,
silver content, degradation behavior, cytotoxicity, and anti-
bacterial properties of Mg-Ag alloys was revealed. The
microstructure has a strong inﬂuence on the degradation
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behavior of Mg-Ag alloys. The degradation rate will be high if
there are many precipitates in the Mg-Ag alloys. To reach a
lower degradation rate, the microstructure was adjusted via
solution treatment (T4). As a result, precipitates dissolved
into the magnesium matrix and the grains enlarged. T4-
treated Mg-Ag alloys showed low degradation rate as pure
Mg and more homogeneous degradation than pure Mg.
The T4-treated Mg-Ag alloys had no discernible in vitro
cytotoxicity to human primary osteoblasts compared with
pure Mg. Moreover, the antibacterial properties depend on
silver release. By increasing the silver content and controlling
the degradation rate, the T4-treated Mg-Ag alloys showed
good antibacterial properties in the bioreactor system with
ﬂow conditions and abundant bacteria inside.
Conflicts of Interest
The authors declare that there is no conﬂict of interest
regarding the publication of this paper.
Acknowledgments
Zhidan Liu thanks the ﬁnancial support of CSC (China
Scholarship Council). The authors would like to acknowledge
Gábor Szakács for helping with casting and hot extrusion,
Gabriele Salamon for the isolation of human primary
osteoblasts, and Juliane Zirm for bacteria counting. During
the sample preparation, Monika Luczak provided great
assistance and Gert Wiese provided helpful support in the
metallography preparation. The research leading to these
results received funding from the Helmholtz Virtual Institute
“In vivo studies of biodegradable magnesium based implant
materials (MetBioMat)” under Grant agreement no. VH-VI-523.
References
[1] M.A.Olsen, J. J. Nepple, K. D. Riew et al., “Risk factors for surgical
site infection following orthopaedic spinal operations,” The
Journal of Bone & Joint Surgery, vol. 90, no. 1, pp. 62–69, 2008.
[2] G. Reid, “Bioﬁlms in infectious disease and on medical
devices,” International Journal of Antimicrobial Agents,
vol. 11, no. 3, pp. 223–226, 1999.
[3] A. Fernandes and M. Dias, “The microbiological proﬁles of
infected prosthetic implants with an emphasis on the organ-
isms which form bioﬁlms,” Journal of Clinical and Diagnostic
Research, vol. 7, no. 2, p. 219, 2013.
[4] R. A. Brady, J. G. Leid, J. H. Calhoun, J. W. Costerton, and
M. E. Shirtliﬀ, “Osteomyelitis and the role of bioﬁlms in
chronic infection,” FEMS Immunology & Medical Microbiol-
ogy, vol. 52, no. 1, pp. 13–22, 2008.
[5] P. Vergidis and R. Patel, “Novel approaches to the diagnosis,
prevention, and treatment of medical device-associated infec-
tions,” Infectious Disease Clinics of North America, vol. 26,
no. 1, pp. 173–186, 2012.
[6] J. Gallo, M. Holinka, and C. S. Moucha, “Antibacterial surface
treatment for orthopaedic implants,” International Journal of
Molecular Sciences, vol. 15, no. 8, pp. 13849–13880, 2014.
[7] H. Qin, H. Cao, Y. Zhao et al., “In vitro and in vivo anti-bioﬁlm
eﬀects of silver nanoparticles immobilized on titanium,” Bio-
materials, vol. 35, no. 33, pp. 9114–9125, 2014.
[8] G. Song, “Control of biodegradation of biocompatable
magnesium alloys,” Corrosion Science, vol. 49, no. 4,
pp. 1696–1701, 2007.
[9] D. A. Robinson, R. W. Griﬃth, D. Shechtman, R. B. Evans, and
M. G. Conzemius, “In vitro antibacterial properties of magne-
sium metal against Escherichia coli, Pseudomonas aeruginosa
and Staphylococcus aureus,” Acta Biomaterialia, vol. 6, no. 5,
pp. 1869–1877, 2010.
[10] H. Qin, Y. Zhao, M. Cheng et al., “Anti-bioﬁlm properties of
magnesium metal via alkaline pH,” RSC Advances, vol. 5,
no. 28, pp. 21434–21444, 2015.
[11] M. I. Rahim, R. Eiﬂer, B. Rais, and P. P. Mueller, “Alkalization
is responsible for antibacterial eﬀects of corroding magne-
sium,” Journal of Biomedical Materials Research Part A,
vol. 103, no. 11, pp. 3526–3532, 2015.
[12] G. Song and A. Atrens, “Understanding magnesium corro-
sion,” Advanced Engineering Materials, vol. 5, no. 12,
pp. 837–858, 2003.
[13] A. Nostro, L. Cellini, M. Di Giulio et al., “Eﬀect of alkaline pH
on staphylococcal bioﬁlm formation,” APMIS, vol. 120, no. 9,
pp. 733–742, 2012.
[14] J. Zeng, L. Ren, Y. Yuan et al., “Short-term eﬀect of magnesium
implantation on the osteomyelitis modeled animals induced
by Staphylococcus aureus,” Journal of Materials Science: Mate-
rials in Medicine, vol. 24, no. 10, pp. 2405–2416, 2013.
[15] M. P. Staiger, A. M. Pietak, J. Huadmai, and G. Dias, “Magne-
sium and its alloys as orthopedic biomaterials: a review,” Bio-
materials, vol. 27, no. 9, pp. 1728–1734, 2006.
[16] F. Witte, J. Fischer, J. Nellesen et al., “In vitro and in vivo cor-
rosion measurements of magnesium alloys,” Biomaterials,
vol. 27, no. 7, pp. 1013–1018, 2006.
[17] D. Xue, Y. Yun, Z. Tan, Z. Dong, and M. J. Schulz, “In vivo and
in vitro degradation behavior of magnesium alloys as biomate-
rials,” Journal of Materials Science & Technology, vol. 28, no. 3,
pp. 261–267, 2012.
[18] J. Walker, S. Shadanbaz, N. T. Kirkland et al., “Magnesium
alloys: predicting in vivo corrosion with in vitro immersion
testing,” Journal of Biomedical Materials Research Part B:
Applied Biomaterials, vol. 100, no. 4, pp. 1134–1141, 2012.
[19] R. J. White, “An historical overview of the use of silver in
wound management,” British Journal of Community Nursing,
vol. 6, Suplement 1, pp. 3–8, 2001.
[20] L. Actis, L. Gaviria, T. Guda, and J. L. Ong, “Antimicrobial sur-
faces for craniofacial implants: state of the art,” Journal of the
Korean Association of Oral and Maxillofacial Surgeons,
vol. 39, no. 2, pp. 43–54, 2013.
[21] H.-J. Park, J. Y. Kim, J. Kim et al., “Silver-ion-mediated reac-
tive oxygen species generation aﬀecting bactericidal activity,”
Water Research, vol. 43, no. 4, pp. 1027–1032, 2009.
[22] C. Marambio-Jones and E. M. Hoek, “A review of the antibac-
terial eﬀects of silver nanomaterials and potential implications
for human health and the environment,” Journal of Nanopar-
ticle Research, vol. 12, no. 5, pp. 1531–1551, 2010.
[23] R. O. Becker, “Silver ions in the treatment of local infections,”
Metal-Based Drugs, vol. 6, no. 4-5, pp. 311–314, 1999.
[24] S. Jacquart, R. Siadous, C. Henocq-Pigasse et al., “Composition
and properties of silver-containing calcium carbonate–cal-
cium phosphate bone cement,” Journal of Materials Science:
Materials in Medicine, vol. 24, no. 12, pp. 2665–2675, 2013.
[25] B. Hussmann, I. Johann, M. Kauther, S. Landgraeber, M. Jäger,
and S. Lendemans, “Measurement of the silver ion
12 Oxidative Medicine and Cellular Longevity
concentration in wound ﬂuids after implantation of silver-
coated megaprostheses: correlation with the clinical outcome,”
BioMed Research International, vol. 2013, Article ID 763096,
11 pages, 2013.
[26] J. Hardes, A. Streitburger, H. Ahrens et al., “The inﬂuence of
elementary silver versus titanium on osteoblasts behaviour
in vitro using human osteosarcoma cell lines,” Sarcoma,
vol. 2007, Article ID 26539, 5 pages, 2007.
[27] A. Gettler, C. Rhoads, and S. Weiss, “A contribution to the
pathology of generalized argyria with a discussion of the fate
of silver in the human body,” The American Journal of Pathol-
ogy, vol. 3, no. 6, p. 631, 1927.
[28] H. Aoyagi and S.-i. Iwasaki, “Long-term eﬀect of silver pow-
der in vivo,” Dental Materials Journal, vol. 27, no. 4,
pp. 612–625, 2008.
[29] A. B. Lansdown, “A pharmacological and toxicological proﬁle
of silver as an antimicrobial agent in medical devices,”
Advances in Pharmacological Sciences, vol. 2010, Article ID
910686, 16 pages, 2010.
[30] L. E. Gaul and A. Staud, “Clinical spectroscopy: seventy cases
of generalized argyrosis following organic and colloidal silver
medication, including a biospectrometric analysis of ten
cases,” Journal of the American Medical Association, vol. 104,
no. 16, pp. 1387–1390, 1935.
[31] J. W. Pifer, B. R. Friedlander, R. T. Kintz, and D. K. Stockdale,
“Absence of toxic eﬀects in silver reclamation workers,” Scan-
dinavian Journal of Work, Environment & Health, vol. 15,
no. 3, pp. 210–221, 1989.
[32] C. Baldi, C. Minoia, A. Di Nucci, E. Capodaglio, and L. Manzo,
“Eﬀects of silver in isolated rat hepatocytes,” Toxicology Let-
ters, vol. 41, no. 3, pp. 261–268, 1988.
[33] Y. S. Kim, M. Y. Song, J. D. Park et al., “Subchronic oral toxic-
ity of silver nanoparticles,” Particle and Fibre Toxicology,
vol. 7, no. 1, p. 20, 2010.
[34] P. L. Drake and K. J. Hazelwood, “Exposure-related health
eﬀects of silver and silver compounds: a review,” Annals of
Occupational Hygiene, vol. 49, no. 7, pp. 575–585, 2005.
[35] R. O. Darouiche, “Treatment of infections associated with sur-
gical implants,” New England Journal of Medicine, vol. 350,
no. 14, pp. 1422–1429, 2004.
[36] S. D. Puckett, E. Taylor, T. Raimondo, and T. J. Webster, “The
relationship between the nanostructure of titanium surfaces
and bacterial attachment,” Biomaterials, vol. 31, no. 4,
pp. 706–713, 2010.
[37] V. K. Truong, R. Lapovok, Y. S. Estrin et al., “The inﬂuence of
nano-scale surface roughness on bacterial adhesion to
ultraﬁne-grained titanium,” Biomaterials, vol. 31, no. 13,
pp. 3674–3683, 2010.
[38] M. Yoshinari, Y. Oda, T. Kato, and K. Okuda, “Inﬂuence of
surface modiﬁcations to titanium on antibacterial activity
in vitro,” Biomaterials, vol. 22, no. 14, pp. 2043–2048, 2001.
[39] Y. Zhao, M. I. Jamesh, W. K. Li et al., “Enhanced antimicrobial
properties, cytocompatibility, and corrosion resistance of
plasma-modiﬁed biodegradable magnesium alloys,” Acta
Biomaterialia, vol. 10, no. 1, pp. 544–556, 2014.
[40] N. J. Hickok and I. M. Shapiro, “Immobilized antibiotics to
prevent orthopaedic implant infections,” Advanced Drug
Delivery Reviews, vol. 64, no. 12, pp. 1165–1176, 2012.
[41] A. Nayeb-Hashemi and J. Clark, “The Ag-Mg (silver-magne-
sium) system,” Bulletin of Alloy Phase Diagrams, vol. 5, no. 4,
pp. 348–358, 1984.
[42] F. Feyerabend, H. Drücker, D. Laipple et al., “Ion release from
magnesium materials in physiological solutions under diﬀer-
ent oxygen tensions,” Journal of Materials Science: Materials
in Medicine, vol. 23, no. 1, pp. 9–24, 2012.
[43] L. Yang, N. Hort, R. Willumeit, and F. Feyerabend, “Eﬀects of
corrosion environment and proteins on magnesium corro-
sion,” Corrosion Engineering, Science and Technology, vol. 47,
no. 5, pp. 335–339, 2012.
[44] F. Feyerabend, M. Johannisson, Z. Liu, and R. Willumeit-
Römer, “Inﬂuence of various sterilization methods on
hardness, grain size and corrosion rate of a Mg6Ag-alloy,” Bio-
NanoMaterials, vol. 16, no. 1, pp. 51–58, 2015.
[45] S. Nagel-Heyer, C. Goepfert, F. Feyerabend et al., “Bioreactor
cultivation of three-dimensional cartilage-carrier-constructs,”
Bioprocess and Biosystems Engineering, vol. 27, no. 4,
pp. 273–280, 2005.
[46] L. Scorzolini, M. Lichtner, M. Iannetta et al., “Sonication tech-
nique improves microbiological diagnosis in patients treated
with antibiotics before surgery for prosthetic joint infections,”
The New Microbiologica, vol. 37, no. 3, pp. 321–328, 2014.
[47] K. E. Piper, M. J. Jacobson, R. H. Coﬁeld et al., “Microbiologic
diagnosis of prosthetic shoulder infection by use of implant
sonication,” Journal of Clinical Microbiology, vol. 47, no. 6,
pp. 1878–1884, 2009.
[48] M. Ribeiro, F. J. Monteiro, and M. P. Ferraz, “Infection of
orthopedic implants with emphasis on bacterial adhesion pro-
cess and techniques used in studying bacterial-material inter-
actions,” Biomatter, vol. 2, no. 4, pp. 176–194, 2012.
[49] A. Bogut, J. Niedźwiadek, D. Strzelec-Nowak et al., “Infectious
prosthetic hip joint loosening: bacterial species involved in its
aetiology and their antibiotic resistance proﬁles against antibi-
otics recommended for the therapy of implant-associated
infections,” The New Microbiologica, vol. 37, no. 2, pp. 209–
218, 2014.
[50] H. Shen, J. Tang, Y. Mao et al., “Pathogenic analysis in diﬀer-
ent types of orthopedic implant infections,” Chinese Medical
Journal, vol. 127, no. 15, pp. 2748–2752, 2014.
[51] H. Rohde, E. C. Burandt, N. Siemssen et al., “Polysaccharide
intercellular adhesin or protein factors in bioﬁlm accumula-
tion of Staphylococcus epidermidis and Staphylococcus aureus
isolated from prosthetic hip and knee joint infections,” Bioma-
terials, vol. 28, no. 9, pp. 1711–1720, 2007.
[52] F. Witte, V. Kaese, H. Haferkamp et al., “In vivo corrosion of
four magnesium alloys and the associated bone response,” Bio-
materials, vol. 26, no. 17, pp. 3557–3563, 2005.
[53] Z. Li, X. Gu, S. Lou, and Y. Zheng, “The development of binary
Mg–Ca alloys for use as biodegradable materials within bone,”
Biomaterials, vol. 29, no. 10, pp. 1329–1344, 2008.
[54] F. Witte, N. Hort, C. Vogt et al., “Degradable biomaterials
based on magnesium corrosion,” Current Opinion in Solid
State and Materials Science, vol. 12, no. 5, pp. 63–72, 2008.
[55] S. Zhang, X. Zhang, C. Zhao et al., “Research on an Mg–Zn
alloy as a degradable biomaterial,” Acta Biomaterialia, vol. 6,
no. 2, pp. 626–640, 2010.
[56] D. Tie, F. Feyerabend, W.-D. Müller et al., “Antibacterial
biodegradable Mg-Ag alloys,” European Cells and Materials,
vol. 25, pp. 284–298, 2013.
[57] E. Ghali, W. Dietzel, and K.-U. Kainer, “General and localized
corrosion of magnesium alloys: a critical review,” Journal of
Materials Engineering and Performance, vol. 13, no. 1,
pp. 7–23, 2004.
13Oxidative Medicine and Cellular Longevity
[58] J. Fischer, D. Pröfrock, N. Hort, R. Willumeit, and F. Feyera-
bend, “Reprint of: improved cytotoxicity testing of magnesium
materials,” Materials Science and Engineering: B, vol. 176,
no. 20, pp. 1773–1777, 2011.
[59] T. R. Garrett, M. Bhakoo, and Z. Zhang, “Bacterial adhesion
and bioﬁlms on surfaces,” Progress in Natural Science,
vol. 18, no. 9, pp. 1049–1056, 2008.
[60] C. Seal, K. Vince, and M. Hodgson, Biodegradable Surgical
Implants Based on Magnesium Alloys–A Review of Current
Research, IOP Conference Series: Materials Science and Engi-
neering, p. 012011, IOP Publishing, Bristol, England, 2009.
[61] V. K. Sharma, K. M. Siskova, R. Zboril, and J. L. Gardea-
Torresdey, “Organic-coated silver nanoparticles in biological
and environmental conditions: fate, stability and toxicity,”
Advances in Colloid and Interface Science, vol. 204,
pp. 15–34, 2014.
[62] N. Shahabadi, M. Maghsudi, and Z. Ahmadipour, “Study on
the interaction of silver (I) complex with bovine serum
albumin by spectroscopic techniques,” Spectrochimica Acta
Part A: Molecular and Biomolecular Spectroscopy, vol. 92,
pp. 184–188, 2012.
14 Oxidative Medicine and Cellular Longevity
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
